See more : Hubei Guochuang Hi-tech Material Co.,Ltd (002377.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Sharps Compliance Corp. (SMED) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sharps Compliance Corp., a leading company in the Waste Management industry within the Industrials sector.
- C&S Paper Co.,Ltd (002511.SZ) Income Statement Analysis – Financial Results
- China General Plastics Corporation (1305.TW) Income Statement Analysis – Financial Results
- COLTENE Holding AG (0QP7.L) Income Statement Analysis – Financial Results
- Cortland Bancorp (CLDB) Income Statement Analysis – Financial Results
- Propanc Biopharma, Inc. (PPCBD) Income Statement Analysis – Financial Results
Sharps Compliance Corp. (SMED)
About Sharps Compliance Corp.
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76.42M | 51.15M | 44.31M | 40.14M | 38.19M | 33.38M | 30.90M | 26.57M | 21.53M | 21.79M | 19.40M | 39.16M | 20.30M | 12.84M | 11.96M | 10.56M | 9.00M | 8.62M | 8.42M | 6.51M | 4.65M | 4.20M | 2.33M | 730.00K | 455.00K |
| Cost of Revenue | 47.51M | 35.38M | 31.04M | 28.74M | 26.35M | 22.27M | 19.91M | 17.58M | 15.18M | 15.25M | 13.17M | 15.50M | 9.84M | 7.73M | 6.94M | 6.07M | 5.50M | 5.11M | 5.80M | 4.36M | 2.33M | 2.24M | 1.43M | 560.00K | 225.00K |
| Gross Profit | 28.91M | 15.76M | 13.27M | 11.40M | 11.84M | 11.11M | 11.00M | 8.99M | 6.35M | 6.54M | 6.22M | 23.65M | 10.46M | 5.11M | 5.01M | 4.49M | 3.50M | 3.51M | 2.62M | 2.15M | 2.32M | 1.96M | 908.44K | 170.00K | 230.00K |
| Gross Profit Ratio | 37.83% | 30.82% | 29.95% | 28.40% | 31.00% | 33.28% | 35.58% | 33.83% | 29.48% | 30.02% | 32.09% | 60.41% | 51.52% | 39.83% | 41.93% | 42.55% | 38.90% | 40.73% | 31.13% | 33.04% | 49.85% | 46.77% | 38.91% | 23.29% | 50.55% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 14.05M | 12.00M | 11.17M | 12.22M | 10.81M | 9.50M | 9.10M | 8.62M | 8.61M | 9.84M | 8.82M | 6.09M | 4.78M | 3.95M | 3.96M | 3.51M | 3.42M | 3.75M | 2.89M | 3.21M | 3.17M | 2.92M | 1.19M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 15.76M | 14.05M | 12.00M | 11.17M | 12.22M | 10.81M | 9.50M | 9.10M | 8.62M | 8.61M | 9.84M | 8.82M | 6.09M | 4.78M | 3.95M | 3.96M | 3.51M | 3.42M | 3.75M | 2.89M | 3.21M | 3.17M | 2.92M | 1.19M | 0.00 |
| Other Expenses | 16.61M | 806.00K | 820.00K | 811.00K | 801.00K | 294.00K | 263.00K | 462.00K | 437.00K | 453.00K | 353.00K | 441.00K | 387.56K | 333.15K | 340.50K | 154.48K | 157.46K | 160.64K | 150.29K | 117.40K | 112.36K | 124.05K | 66.06K | 20.00K | 486.00K |
| Operating Expenses | 16.61M | 14.85M | 12.82M | 11.98M | 13.02M | 11.11M | 9.76M | 9.56M | 9.06M | 9.06M | 10.19M | 9.26M | 6.48M | 5.12M | 4.29M | 4.11M | 3.67M | 3.58M | 3.90M | 3.01M | 3.32M | 3.29M | 2.98M | 1.21M | 486.00K |
| Cost & Expenses | 64.12M | 50.24M | 43.87M | 40.72M | 39.38M | 33.38M | 29.67M | 27.14M | 24.24M | 24.31M | 23.36M | 24.76M | 16.32M | 12.84M | 11.23M | 10.18M | 9.17M | 8.69M | 9.70M | 7.37M | 5.65M | 5.53M | 4.41M | 1.77M | 711.00K |
| Interest Income | 0.00 | 14.00K | 24.00K | 20.00K | 13.00K | 32.00K | 36.00K | 24.00K | 27.00K | 36.00K | 55.00K | 37.00K | 27.24K | 85.26K | 50.68K | 0.00 | 0.00 | 0.00 | 16.56K | 41.72K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 194.00K | 127.00K | 87.00K | 94.00K | 115.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -44.00 | -4.61K | 0.00 | 0.00 | 0.00 | -10.97K | -2.11K | 0.00 | 0.00 | 0.00 | 80.00K | 0.00 |
| Depreciation & Amortization | 1.99M | 1.61M | 1.66M | 1.56M | 1.49M | 816.00K | 830.00K | 1.11M | 1.10M | 1.12M | 1.00M | 796.00K | 418.45K | 265.61K | 202.50K | 154.48K | 157.46K | 160.64K | 150.29K | 117.40K | 112.36K | 124.05K | 114.06K | 10.00K | 151.00K |
| EBITDA | 16.52M | 2.42M | 2.13M | 1.00M | 311.00K | 853.00K | 1.54M | 1.45M | -1.59M | -1.38M | -3.49M | 14.88M | 3.88M | 350.63K | 1.01M | 536.10K | -35.64K | 42.77K | -1.13M | -701.64K | -849.19K | -1.16M | -1.82M | -870.00K | -122.00K |
| EBITDA Ratio | 21.62% | 4.73% | 4.82% | 2.50% | 0.81% | 2.56% | 6.80% | 7.88% | -7.40% | -6.34% | -17.98% | 38.90% | 19.29% | 2.73% | 8.43% | 5.08% | -0.40% | 0.50% | -13.39% | -10.77% | -18.26% | -27.55% | -78.14% | -119.18% | -26.81% |
| Operating Income | 12.30M | 910.00K | 447.00K | -577.00K | -1.19M | 5.00K | 1.24M | 965.00K | -2.71M | -2.52M | -4.54M | 14.40M | 3.46M | -696.00 | 727.31K | 382.19K | -170.23K | -69.14K | -1.28M | -858.65K | -1.00M | -1.33M | -2.08M | -1.04M | -256.00K |
| Operating Income Ratio | 16.10% | 1.78% | 1.01% | -1.44% | -3.11% | 0.01% | 4.00% | 3.63% | -12.58% | -11.57% | -23.39% | 36.77% | 17.07% | -0.01% | 6.08% | 3.62% | -1.89% | -0.80% | -15.24% | -13.18% | -21.50% | -31.60% | -88.91% | -142.47% | -56.26% |
| Total Other Income/Expenses | 2.04M | -226.00K | -63.00K | -74.00K | -102.00K | 32.00K | 36.00K | 24.00K | 12.00K | 23.00K | 45.00K | 37.00K | 33.23K | 85.72K | 78.58K | 0.00 | 0.00 | 0.00 | 5.59K | 39.61K | 0.00 | 0.00 | 0.00 | 80.00K | 11.00K |
| Income Before Tax | 14.34M | 684.00K | 384.00K | -651.00K | -1.29M | 37.00K | 1.27M | 989.00K | -2.70M | -2.50M | -4.49M | 14.44M | 3.50M | 85.02K | 805.88K | 0.00 | 0.00 | 0.00 | -1.28M | -819.04K | 0.00 | 0.00 | 0.00 | -960.00K | -245.00K |
| Income Before Tax Ratio | 18.76% | 1.34% | 0.87% | -1.62% | -3.38% | 0.11% | 4.12% | 3.72% | -12.53% | -11.47% | -23.16% | 36.87% | 17.23% | 0.66% | 6.74% | 0.00% | 0.00% | 0.00% | -15.17% | -12.58% | 0.00% | 0.00% | 0.00% | -131.51% | -53.85% |
| Income Tax Expense | 1.47M | -1.58M | 170.00K | 21.00K | 4.00K | 24.00K | 112.00K | 33.00K | 15.00K | 1.12M | -1.52M | 5.08M | -699.85K | 3.45K | 21.18K | 0.00 | 0.00 | 0.00 | 5.59K | 39.61K | 0.00 | 0.00 | 0.00 | 160.00K | 11.00K |
| Net Income | 12.87M | 2.27M | 214.00K | -672.00K | -1.29M | 13.00K | 1.16M | 956.00K | -2.71M | -3.62M | -2.98M | 9.36M | 4.20M | 81.57K | 784.70K | 381.63K | -193.10K | -117.88K | -1.28M | -819.04K | -961.55K | -1.28M | -1.94M | -960.00K | -273.00K |
| Net Income Ratio | 16.84% | 4.43% | 0.48% | -1.67% | -3.39% | 0.04% | 3.75% | 3.60% | -12.60% | -16.62% | -15.34% | 23.89% | 20.68% | 0.64% | 6.56% | 3.61% | -2.15% | -1.37% | -15.17% | -12.58% | -20.67% | -30.50% | -83.02% | -131.51% | -60.00% |
| EPS | 0.76 | 0.14 | 0.01 | -0.04 | -0.08 | 0.00 | 0.08 | 0.06 | -0.18 | -0.24 | -0.20 | 0.66 | 0.33 | 0.01 | 0.07 | 0.04 | -0.02 | -0.01 | -0.13 | -0.09 | -0.11 | -0.17 | -0.25 | -0.14 | -0.10 |
| EPS Diluted | 0.76 | 0.14 | 0.01 | -0.04 | -0.08 | 0.00 | 0.07 | 0.06 | -0.18 | -0.24 | -0.20 | 0.63 | 0.30 | 0.01 | 0.06 | 0.03 | -0.02 | -0.01 | -0.13 | -0.09 | -0.11 | -0.17 | -0.25 | -0.14 | -0.10 |
| Weighted Avg Shares Out | 17.03M | 16.43M | 16.12M | 16.06M | 15.95M | 15.45M | 15.33M | 15.29M | 15.26M | 15.11M | 14.94M | 14.18M | 12.91M | 12.31M | 11.16M | 10.55M | 10.54M | 10.39M | 9.86M | 9.50M | 8.46M | 7.63M | 7.62M | 6.77M | 2.63M |
| Weighted Avg Shares Out (Dil) | 17.03M | 16.43M | 16.12M | 16.06M | 15.95M | 15.84M | 15.56M | 15.40M | 15.26M | 15.11M | 14.94M | 14.95M | 14.00M | 13.54M | 12.34M | 10.95M | 10.98M | 10.39M | 9.86M | 9.50M | 8.46M | 7.63M | 7.62M | 6.77M | 2.63M |
SHARPS COMPLIANCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sharps Compliance Corp. - SMED
Sharps Compliance (SMED) To Be Acquired For $8.75 Per Share
Sharps Compliance: PE Deal Causes Me To Reflect
Why Is Sharps Compliance (SMED) Stock Up 200% Today?
SMED Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sharps Compliance Corp. Is Fair to Shareholders
Sharps Compliance Corp. (SMED) CEO Pat Mulloy on Q3 2022 Results - Earnings Call Transcript
Sharps Compliance (SMED) Reports Q3 Loss, Tops Revenue Estimates
Sharps Compliance Reschedules Third Quarter Fiscal 2022 Conference Call and Webcast
Sharps Compliance: Update Prior To Important Earnings
Sharps Compliance Announces Third Quarter Fiscal 2022 Conference Call and Webcast
Source: https://incomestatements.info
Category: Stock Reports